These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34095884)

  • 1. PFC mTOR signaling as a biological signature for cognitive deficits in bipolar disorder without psychosis.
    Radulovic J; Gabbay V
    Cell Rep Med; 2021 May; 2(5):100282. PubMed ID: 34095884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt-mTOR hypoactivity in bipolar disorder gives rise to cognitive impairments associated with altered neuronal structure and function.
    Vanderplow AM; Eagle AL; Kermath BA; Bjornson KJ; Robison AJ; Cahill ME
    Neuron; 2021 May; 109(9):1479-1496.e6. PubMed ID: 33765445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis.
    Bora E
    J Affect Disord; 2018 Mar; 229():125-134. PubMed ID: 29306692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential impairment of social cognition factors in bipolar disorder with and without psychotic features and schizophrenia.
    Thaler NS; Allen DN; Sutton GP; Vertinski M; Ringdahl EN
    J Psychiatr Res; 2013 Dec; 47(12):2004-10. PubMed ID: 24112946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive markers of psychosis in bipolar disorder: a meta-analytic study.
    Bora E; Yücel M; Pantelis C
    J Affect Disord; 2010 Dec; 127(1-3):1-9. PubMed ID: 20231037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of psychosis on brain anatomy in bipolar disorder: A structural MRI study.
    Altamura AC; Maggioni E; Dhanoa T; Ciappolino V; Paoli RA; Cremaschi L; Prunas C; Orsenigo G; Caletti E; Cinnante CM; Triulzi FM; Dell'Osso B; Yatham L; Brambilla P
    J Affect Disord; 2018 Jun; 233():100-109. PubMed ID: 29223329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Hill SK; Reilly JL; Keefe RS; Gold JM; Bishop JR; Gershon ES; Tamminga CA; Pearlson GD; Keshavan MS; Sweeney JA
    Am J Psychiatry; 2013 Nov; 170(11):1275-84. PubMed ID: 23771174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurocognitive signature of psychotic bipolar disorder.
    Glahn DC; Bearden CE; Barguil M; Barrett J; Reichenberg A; Bowden CL; Soares JC; Velligan DI
    Biol Psychiatry; 2007 Oct; 62(8):910-6. PubMed ID: 17543288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cigarette smoking behavior and psychosis history on general and social cognition in bipolar disorder.
    Ospina LH; Russo M; Nitzburg GM; Cuesta-Diaz A; Shanahan M; Perez-Rodriguez MM; Mcgrath M; Levine H; Mulaimovic S; Burdick KE
    Bipolar Disord; 2016 Sep; 18(6):528-538. PubMed ID: 27650399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working memory predicts presence of auditory verbal hallucinations in schizophrenia and bipolar disorder with psychosis.
    Jenkins LM; Bodapati AS; Sharma RP; Rosen C
    J Clin Exp Neuropsychol; 2018 Feb; 40(1):84-94. PubMed ID: 28562181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis.
    Bowie CR; Best MW; Depp C; Mausbach BT; Patterson TL; Pulver AE; Harvey PD
    Bipolar Disord; 2018 Nov; 20(7):604-613. PubMed ID: 29777563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain-processing abnormalities in bipolar I disorder, bipolar II disorder, and schizophrenia: A novel trait marker for psychosis proneness and functional outcome?
    Minichino A; Delle Chiaie R; Cruccu G; Piroso S; Di Stefano G; Francesconi M; Bersani FS; Biondi M; Truini A
    Bipolar Disord; 2016 Nov; 18(7):591-601. PubMed ID: 27782355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.
    Ethridge LE; Soilleux M; Nakonezny PA; Reilly JL; Hill SK; Keefe RS; Gershon ES; Pearlson GD; Tamminga CA; Keshavan MS; Sweeney JA
    Schizophr Res; 2014 Nov; 159(2-3):491-8. PubMed ID: 25261042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.
    Machado-Vieira R; Zanetti MV; Teixeira AL; Uno M; Valiengo LL; Soeiro-de-Souza MG; Oba-Shinjo SM; de Sousa RT; Zarate CA; Gattaz WF; Marie SK
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):468-73. PubMed ID: 25726893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder.
    Brosey E; Woodward ND
    Schizophr Res; 2015 Aug; 166(1-3):92-7. PubMed ID: 26002072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological status of bipolar I disorder: impact of psychosis.
    Savitz J; van der Merwe L; Stein DJ; Solms M; Ramesar R
    Br J Psychiatry; 2009 Mar; 194(3):243-51. PubMed ID: 19252155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive endophenotypes of psychosis within dimension and diagnosis.
    Ivleva EI; Morris DW; Osuji J; Moates AF; Carmody TJ; Thaker GK; Cullum M; Tamminga CA
    Psychiatry Res; 2012 Mar; 196(1):38-44. PubMed ID: 22342122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.
    Reilly JL; Sweeney JA
    Schizophr Bull; 2014 May; 40(3):516-22. PubMed ID: 24574307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.